Caixa Capital Risc divests Sanifit Therapeutics to Vifor Pharma
CriteriaCaixa's venture capital subsidiary Caixa Capital Risc has sold Sanifit Therapeutics to Vifor Pharma, a global pharmaceutical company.
CriteriaCaixa's venture capital subsidiary Caixa Capital Risc has sold Sanifit Therapeutics to Vifor Pharma, a global pharmaceutical company.
Copyright PEI Media
Not for publication, email or dissemination